Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: IMARC | PRODUCT CODE: 1541272

Cover Image

PUBLISHER: IMARC | PRODUCT CODE: 1541272

Post-marketing Pharmacovigilance and Medical Information Market Report by Type, Product, End User, and Region 2024-2032

PUBLISHED:
PAGES: 136 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 2999
PDF & Excel (5 User License)
USD 3999
PDF & Excel (Corporate License)
USD 4999

Add to Cart

The global post-marketing pharmacovigilance and medical information market size reached US$ 5.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 13.0 Billion by 2032, exhibiting a growth rate (CAGR) of 9.52% during 2024-2032.

Post-marketing pharmacovigilance and medical information is the practice of monitoring the safety and efficacy of drugs and medical devices after their launch. It includes collection, surveillance, and prevention of adverse effects of new medicines, equipment, and therapies. It helps protect patients from unnecessary harm by clarifying risks concerning benefits and refuting false indications. Besides this, it assists researchers in determining required actions throughout the drug formulation cycle. As a result, post-marketing pharmacovigilance and medical information finds a considerable role in the healthcare industry to assess the accuracy of the delivered information between patients and medical professionals. It is also used in research organizations for regulating drug safety guidelines.

Post-marketing Pharmacovigilance and Medical Information Market Trends:

The growing global geriatric population and the rising occurrence of various chronic medical disorders, such as diabetes, hypertension, dementia, cardiovascular diseases, and osteoporosis, represent one of the key factors increasing the consumption of medicines. In addition, the increasing frequency of lifestyle, respiratory and cardiovascular infections, and neurological and oncological diseases are resulting in the increasing sales of drugs worldwide. This, in turn, is creating a positive market outlook. In line with this, the rising prevalence of Adverse Drug Reactions (ADRs), coupled with the incorporation of advanced ADR reporting tools, is supporting the market growth. Apart from this, the expansion of hospitals, clinics, laboratories, and medical research centers is catalyzing the demand for medications and medical devices across the globe. Moreover, governments of various countries are implementing several initiatives to improve healthcare infrastructure and pharmacovigilance services and maintain medical databases, which is strengthening the market growth. Furthermore, leading market players are focusing on outsourcing pharmacovigilance operations (PVO) and introducing cloud-based medical information systems for optimal accuracy, cost efficiency, risk mitigation, domain, improved timelines, and organizational agility, which is anticipated to drive the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global post-marketing pharmacovigilance and medical information market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, product and end user.

Breakup by Type:

Spontaneous Reporting

Intensified ADR Reporting

Targeted Spontaneous Reporting

Cohort Event Monitoring

EHR Mining

Breakup by Product:

Books

Online Media

Journals

Breakup by End User:

Hospitals

Research Organization

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Accenture Plc., ArisGlobal, Cognizant Technology Solutions Corporation, Ergomed Plc, F. Hoffmann-La Roche Ltd., Icon Plc, Parexel International Corporation, Pharmaceutical Product Development, Inc. and Wipro Ltd.

Key Questions Answered in This Report

  • 1. How big is the global post-marketing pharmacovigilance and medical information market?
  • 2. What is the expected growth rate of the global post-marketing pharmacovigilance and medical information market during 2024-2032?
  • 3. What are the key factors driving the global post-marketing pharmacovigilance and medical information market?
  • 4. What has been the impact of COVID-19 on the global post-marketing pharmacovigilance and medical information market?
  • 5. What is the breakup of the global post-marketing pharmacovigilance and medical information market based on the type?
  • 6. What is the breakup of the global post-marketing pharmacovigilance and medical information market based on the end user?
  • 7. What are the key regions in the global post-marketing pharmacovigilance and medical information market?
  • 8. Who are the key players/companies in the global post-marketing pharmacovigilance and medical information market?
Product Code: SR112024A6454

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Post-marketing Pharmacovigilance and Medical Information Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Spontaneous Reporting
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Intensified ADR Reporting
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Targeted Spontaneous Reporting
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Cohort Event Monitoring
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 EHR Mining
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Books
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Online Media
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Journals
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Research Organization
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Accenture Plc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 ArisGlobal
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Cognizant Technology Solutions Corporation
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Ergomed Plc
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 F. Hoffmann-La Roche Ltd.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 SWOT Analysis
    • 14.3.6 Icon Plc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Parexel International Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8 Pharmaceutical Product Development, Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 SWOT Analysis
    • 14.3.9 Wipro Ltd.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
Product Code: SR112024A6454

List of Figures

  • Figure 1: Global: Post-marketing Pharmacovigilance and Medical Information Market: Major Drivers and Challenges
  • Figure 2: Global: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Post-marketing Pharmacovigilance and Medical Information Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Post-marketing Pharmacovigilance and Medical Information Market: Breakup by Product (in %), 2023
  • Figure 6: Global: Post-marketing Pharmacovigilance and Medical Information Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Post-marketing Pharmacovigilance and Medical Information Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Post-marketing Pharmacovigilance and Medical Information (Spontaneous Reporting) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Post-marketing Pharmacovigilance and Medical Information (Spontaneous Reporting) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Post-marketing Pharmacovigilance and Medical Information (Intensified ADR Reporting) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Post-marketing Pharmacovigilance and Medical Information (Intensified ADR Reporting) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Post-marketing Pharmacovigilance and Medical Information (Targeted Spontaneous Reporting) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Post-marketing Pharmacovigilance and Medical Information (Targeted Spontaneous Reporting) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Post-marketing Pharmacovigilance and Medical Information (Cohort Event Monitoring) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Post-marketing Pharmacovigilance and Medical Information (Cohort Event Monitoring) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Post-marketing Pharmacovigilance and Medical Information (EHR Mining) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Post-marketing Pharmacovigilance and Medical Information (EHR Mining) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Post-marketing Pharmacovigilance and Medical Information (Books) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Post-marketing Pharmacovigilance and Medical Information (Books) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Post-marketing Pharmacovigilance and Medical Information (Online Media) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Post-marketing Pharmacovigilance and Medical Information (Online Media) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Post-marketing Pharmacovigilance and Medical Information (Journals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Post-marketing Pharmacovigilance and Medical Information (Journals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Post-marketing Pharmacovigilance and Medical Information (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Post-marketing Pharmacovigilance and Medical Information (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Post-marketing Pharmacovigilance and Medical Information (Research Organization) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Post-marketing Pharmacovigilance and Medical Information (Research Organization) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: North America: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: North America: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: United States: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: United States: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Canada: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Canada: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Asia-Pacific: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Asia-Pacific: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: China: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: China: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Japan: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Japan: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: India: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: India: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: South Korea: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: South Korea: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Australia: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Australia: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Indonesia: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Indonesia: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Others: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Others: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Europe: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Europe: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Germany: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Germany: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: France: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: France: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: United Kingdom: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: United Kingdom: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Italy: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Italy: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Spain: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Spain: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Russia: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Russia: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Others: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Others: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Latin America: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Latin America: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Brazil: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Brazil: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Mexico: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Mexico: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Others: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Others: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Middle East and Africa: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Middle East and Africa: Post-marketing Pharmacovigilance and Medical Information Market: Breakup by Country (in %), 2023
  • Figure 76: Middle East and Africa: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Global: Post-marketing Pharmacovigilance and Medical Information Industry: SWOT Analysis
  • Figure 78: Global: Post-marketing Pharmacovigilance and Medical Information Industry: Value Chain Analysis
  • Figure 79: Global: Post-marketing Pharmacovigilance and Medical Information Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Post-marketing Pharmacovigilance and Medical Information Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 4: Global: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Post-marketing Pharmacovigilance and Medical Information Market: Competitive Structure
  • Table 7: Global: Post-marketing Pharmacovigilance and Medical Information Market: Key Players
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!